Accessed Oct 18, 2022 at New analyses of Mounjaro (tirzepatide) injection for the treatment of adults with type 2 diabetes presented at the American Diabetes Association's 82nd Scientific Sessions
A 2022 study from the University of Sheffield unearthed that strategic recalibration of dietary intake, intensification or variation of physical activity, and psychological support were pivotal in catapulting participants past weight loss plateaus
Important limitations include: Most evidence derives from preclinical or observational studies No randomized controlled trials specifically evaluate tirzepatide for autoimmune disease Mechanisms remain incompletely understood Clinical translation of anti-inflammatory effects is uncertain There is currently no established clinical evidence that tirzepatide effectively treats autoimmune diseases
This reduced pancreatic workload is another way does tirzepatide affect pancreas contributes to better metabolic outcomes
GLP-1 receptor agonists are not typically associated with drug-induced liver injury and generally do not cause liver damage
Per-meal protein thresholds are also higher, with 35 to 40 grams per meal needed to maximally stimulate muscle protein synthesis in older muscle